Arca
Skip to content
Tools
Tools

Abscess

Drug research and approvals for abscess: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 35 studies of abscess are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 35
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest start dates first, of 35 recruiting on ClinicalTrials.gov ↗

Drug pipeline

1 approved, 12 in phase 3, 2 in phase 2; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Clindamycin phosphate

Alteplase
Phase 3 Tissue-type plasminogen activator exogenous protein
Vancomycin
Phase 3 Peptidoglycan inhibitor
Fentanyl
Phase 3 Mu opioid receptor agonist
Metronidazole
Phase 3 DNA inhibitor
Moxifloxacin
Phase 3 Topoisomerase IV inhibitor
Sulfamethoxazole
Phase 3 Bacterial dihydropteroate synthase inhibitor
Trimethoprim
Phase 3 Bacterial dihydrofolate reductase inhibitor
Tazobactam
Phase 3 Bacterial beta-lactamase TEM inhibitor
Piperacillin
Phase 3 Bacterial penicillin-binding protein inhibitor
Linezolid
Phase 3 Bacterial 70S ribosome inhibitor
Oritavancin
Phase 3 Peptidoglycan inhibitor
Dalbavancin
Phase 3 Peptidoglycan inhibitor
Methylene blue cation
Phase 2 Reducing agent
Chlorhexidine
Phase 2 Cell membrane inhibitor

How its trials ended

155 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 37 whose ending is known, 38% met their primary endpoint, 3% missed it and 59% stopped early.

  • Completed, result not reported5837%
  • Ongoing4126%
  • Status unknown1912%
  • Met its primary endpoint149%
  • Stopped: other or unclear117%
  • Stopped: enrollment or feasibility85%
  • Missed its primary endpoint11%
  • Stopped: lack of efficacy11%
  • Stopped: sponsor or business decision11%
  • Stopped: funding11%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.